Kim YK, Kim A, Park SJ, & Lee H. (2017). New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients. Dove Medical Press.
Chicago Style (17th ed.) CitationKim YK, Kim A, Park SJ, and Lee H. New Tablet Formulation of Tacrolimus with Smaller Interindividual Variability May Become a Better Treatment Option than the Conventional Capsule Formulation in Organ Transplant Patients. Dove Medical Press, 2017.
MLA (9th ed.) CitationKim YK, et al. New Tablet Formulation of Tacrolimus with Smaller Interindividual Variability May Become a Better Treatment Option than the Conventional Capsule Formulation in Organ Transplant Patients. Dove Medical Press, 2017.